EP 376 Outcomes Following Tumour Debulking and Cytoreductive Surgery for Colorectal Peritoneal Disease: A Single-Centre Case Series

Clicks: 1
ID: 324087
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #426 of 432 articles by views in the british journal of surgery

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 432 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Colorectal Malignancy with peritoneal metastasis is associated with a poor prognosis and high morbidity. Recent Meta-analysis published in colorectal disease 2025 has shown that Cytoreductive surgery may offer symptomatic relief and increase survival in selected patients. However these inventions are associated with significant peri-operative risk. This study reports peri-operative and short term outcomes for patient’s that underwent either Cytoreductive surgery or Tumour debulking surgery at a single centre. Methods A retrospective review was performed of patients undergoing tumour debulking or cytoreductive surgery for colorectal peritoneal disease between 2022–2025. Data collected included patient demographics, post-operative length of stay (LOS), complications graded using the Clavien–Dindo classification, 30-day mortality, and disease recurrence. Results Seventeen patients (10 Tumour debulking and 7 cytoreductive surgery) were included. Median age was 68 years. Median length of stay was 11 days (range 4–38 days). Post-operative complications occurred in 7 patients (41%) of patients. Clavien–Dindo grade I–II complications were observed in 4 patients, while 3 patients experienced major complications (grade III–IV). The 30-day mortality rate was 0%. Overall mortality as of January 2026 was 35%. Four patients had who underwent tumour debulking had died (40%), Two Cytoreductive surgery had passed away (28.5%). Median mortality time was of 11.3 months (range 4 – 22 months). Disease recurrence occurred in 4 patients at a median follow-up of 10 months. Conclusion Tumour debulking and cytoreductive surgery for colorectal peritoneal disease is associated with a significant complication burden and mortality risk even in carefully selected patients. These findings support the role of multidisciplinary patient selection and highlight the importance of counselling regarding peri-operative risks. Further research looking at quality of life for those undergoing primarily tumour debulking would be a valuable measurement and could help aid further decision making in these complex patients.
Reference Key
openalex_W7172541301 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Thomas Whittle, Jamie Park, Ruaridh Glancy
Journal the british journal of surgery
Year 2026
DOI
10.1093/bjs/znag087.581
URL
https://doi.org/10.1093/bjs/znag087.581
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.